Ibogaine-like effects of noribogaine in rats

Ibogaine is a naturally occurring alkaloid that has been claimed to be effective in treating addiction to opioids and stimulants; a single dose is claimed to be effective for 6 months. Analogously, studies in rats have demonstrated prolonged (one or more days) effects of ibogaine on morphine and coc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain research 1996-03, Vol.713 (1), p.294-297
Hauptverfasser: Glick, S.D., Pearl, S.M., Cai, J., Maisonneuve, I.M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 297
container_issue 1
container_start_page 294
container_title Brain research
container_volume 713
creator Glick, S.D.
Pearl, S.M.
Cai, J.
Maisonneuve, I.M.
description Ibogaine is a naturally occurring alkaloid that has been claimed to be effective in treating addiction to opioids and stimulants; a single dose is claimed to be effective for 6 months. Analogously, studies in rats have demonstrated prolonged (one or more days) effects of ibogaine on morphine and cocaine self-administration even though ibogaine is mostly eliminated from the body in several hours. These observations have suggested that a metabolite may mediate some of the effects of ibogaine. Recently, noribogaine was identified as a metabolite of ibogaine. Accordingly, the present study sought to determine, in rats, whether noribogaine had pharmacological effects mimicking those of ibogaine. Noribogaine (40 mg/kg[ was found to decrease morphine and cocaine self-administration, reduce the locomotor stimulant effect of morphine, and decrease extracellular levels of dopamine in the nucleus accumbens and striatum. All of these effects were similar to effects previously observed with ibogaine (40 mg/kg[; however, noribogaine did not induce any ibogaine-like tremors. The results suggest that noribogaine may be a mediator of ibogaine's putative anti-addictive effects.
doi_str_mv 10.1016/0006-8993(95)01563-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17055103</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0006899395015639</els_id><sourcerecordid>17055103</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-86f2b24851894c137858091bf8a2b1efad06b82b0e37b31e2042814b7d179a843</originalsourceid><addsrcrecordid>eNp9kMFqGzEQhkVJcRynb9DAHkJJINvOrKRd6VIIpk0Chl7Ss5C0o6JkvetIdqBvn3W8-JjTMPzfDDMfY18RviNg_QMA6lJpza-0vAaUNS_1JzZH1VRlXQk4YfMjcsrOcn4aW841zNhsZCSAmLObBzf8s7GnsovPVFAI5Le5GELRDylOWRH7ItltPmefg-0yfZnqgv39_etxeV-u_tw9LG9XpRfYbEtVh8pVQklUWnjkjZIKNLqgbOWQgm2hdqpyQLxxHKkCUSkUrmmx0VYJvmDfDns3aXjZUd6adcyeus72NOyywQakxPGXBRMH0Kch50TBbFJc2_TfIJi9JLM3YPYGjJbmXZLR49jFtH_n1tQehyYrY3455TZ724Vkex_zEeOoZA1yxH4eMBpdvEZKJvtIvac2ptGiaYf48R1vxxx_5A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17055103</pqid></control><display><type>article</type><title>Ibogaine-like effects of noribogaine in rats</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Glick, S.D. ; Pearl, S.M. ; Cai, J. ; Maisonneuve, I.M.</creator><creatorcontrib>Glick, S.D. ; Pearl, S.M. ; Cai, J. ; Maisonneuve, I.M.</creatorcontrib><description>Ibogaine is a naturally occurring alkaloid that has been claimed to be effective in treating addiction to opioids and stimulants; a single dose is claimed to be effective for 6 months. Analogously, studies in rats have demonstrated prolonged (one or more days) effects of ibogaine on morphine and cocaine self-administration even though ibogaine is mostly eliminated from the body in several hours. These observations have suggested that a metabolite may mediate some of the effects of ibogaine. Recently, noribogaine was identified as a metabolite of ibogaine. Accordingly, the present study sought to determine, in rats, whether noribogaine had pharmacological effects mimicking those of ibogaine. Noribogaine (40 mg/kg[ was found to decrease morphine and cocaine self-administration, reduce the locomotor stimulant effect of morphine, and decrease extracellular levels of dopamine in the nucleus accumbens and striatum. All of these effects were similar to effects previously observed with ibogaine (40 mg/kg[; however, noribogaine did not induce any ibogaine-like tremors. The results suggest that noribogaine may be a mediator of ibogaine's putative anti-addictive effects.</description><identifier>ISSN: 0006-8993</identifier><identifier>EISSN: 1872-6240</identifier><identifier>DOI: 10.1016/0006-8993(95)01563-9</identifier><identifier>PMID: 8725004</identifier><identifier>CODEN: BRREAP</identifier><language>eng</language><publisher>London: Elsevier B.V</publisher><subject>Animals ; Biological and medical sciences ; Cocaine ; Dopamine ; Drug addictions ; Drug self-administration ; Female ; Ibogaine ; Ibogaine - analogs &amp; derivatives ; Ibogaine - pharmacology ; Locomotion - drug effects ; Medical sciences ; Medicine, African Traditional ; Microdialysis ; Morphine ; Morphine - pharmacology ; Noribogaine ; Rats ; Rats, Sprague-Dawley ; Self Administration ; Substance-Related Disorders - therapy ; Time Factors ; Toxicology</subject><ispartof>Brain research, 1996-03, Vol.713 (1), p.294-297</ispartof><rights>1996</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-86f2b24851894c137858091bf8a2b1efad06b82b0e37b31e2042814b7d179a843</citedby><cites>FETCH-LOGICAL-c417t-86f2b24851894c137858091bf8a2b1efad06b82b0e37b31e2042814b7d179a843</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0006899395015639$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3185605$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8725004$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Glick, S.D.</creatorcontrib><creatorcontrib>Pearl, S.M.</creatorcontrib><creatorcontrib>Cai, J.</creatorcontrib><creatorcontrib>Maisonneuve, I.M.</creatorcontrib><title>Ibogaine-like effects of noribogaine in rats</title><title>Brain research</title><addtitle>Brain Res</addtitle><description>Ibogaine is a naturally occurring alkaloid that has been claimed to be effective in treating addiction to opioids and stimulants; a single dose is claimed to be effective for 6 months. Analogously, studies in rats have demonstrated prolonged (one or more days) effects of ibogaine on morphine and cocaine self-administration even though ibogaine is mostly eliminated from the body in several hours. These observations have suggested that a metabolite may mediate some of the effects of ibogaine. Recently, noribogaine was identified as a metabolite of ibogaine. Accordingly, the present study sought to determine, in rats, whether noribogaine had pharmacological effects mimicking those of ibogaine. Noribogaine (40 mg/kg[ was found to decrease morphine and cocaine self-administration, reduce the locomotor stimulant effect of morphine, and decrease extracellular levels of dopamine in the nucleus accumbens and striatum. All of these effects were similar to effects previously observed with ibogaine (40 mg/kg[; however, noribogaine did not induce any ibogaine-like tremors. The results suggest that noribogaine may be a mediator of ibogaine's putative anti-addictive effects.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cocaine</subject><subject>Dopamine</subject><subject>Drug addictions</subject><subject>Drug self-administration</subject><subject>Female</subject><subject>Ibogaine</subject><subject>Ibogaine - analogs &amp; derivatives</subject><subject>Ibogaine - pharmacology</subject><subject>Locomotion - drug effects</subject><subject>Medical sciences</subject><subject>Medicine, African Traditional</subject><subject>Microdialysis</subject><subject>Morphine</subject><subject>Morphine - pharmacology</subject><subject>Noribogaine</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Self Administration</subject><subject>Substance-Related Disorders - therapy</subject><subject>Time Factors</subject><subject>Toxicology</subject><issn>0006-8993</issn><issn>1872-6240</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFqGzEQhkVJcRynb9DAHkJJINvOrKRd6VIIpk0Chl7Ss5C0o6JkvetIdqBvn3W8-JjTMPzfDDMfY18RviNg_QMA6lJpza-0vAaUNS_1JzZH1VRlXQk4YfMjcsrOcn4aW841zNhsZCSAmLObBzf8s7GnsovPVFAI5Le5GELRDylOWRH7ItltPmefg-0yfZnqgv39_etxeV-u_tw9LG9XpRfYbEtVh8pVQklUWnjkjZIKNLqgbOWQgm2hdqpyQLxxHKkCUSkUrmmx0VYJvmDfDns3aXjZUd6adcyeus72NOyywQakxPGXBRMH0Kch50TBbFJc2_TfIJi9JLM3YPYGjJbmXZLR49jFtH_n1tQehyYrY3455TZ724Vkex_zEeOoZA1yxH4eMBpdvEZKJvtIvac2ptGiaYf48R1vxxx_5A</recordid><startdate>19960325</startdate><enddate>19960325</enddate><creator>Glick, S.D.</creator><creator>Pearl, S.M.</creator><creator>Cai, J.</creator><creator>Maisonneuve, I.M.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>19960325</creationdate><title>Ibogaine-like effects of noribogaine in rats</title><author>Glick, S.D. ; Pearl, S.M. ; Cai, J. ; Maisonneuve, I.M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-86f2b24851894c137858091bf8a2b1efad06b82b0e37b31e2042814b7d179a843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cocaine</topic><topic>Dopamine</topic><topic>Drug addictions</topic><topic>Drug self-administration</topic><topic>Female</topic><topic>Ibogaine</topic><topic>Ibogaine - analogs &amp; derivatives</topic><topic>Ibogaine - pharmacology</topic><topic>Locomotion - drug effects</topic><topic>Medical sciences</topic><topic>Medicine, African Traditional</topic><topic>Microdialysis</topic><topic>Morphine</topic><topic>Morphine - pharmacology</topic><topic>Noribogaine</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Self Administration</topic><topic>Substance-Related Disorders - therapy</topic><topic>Time Factors</topic><topic>Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Glick, S.D.</creatorcontrib><creatorcontrib>Pearl, S.M.</creatorcontrib><creatorcontrib>Cai, J.</creatorcontrib><creatorcontrib>Maisonneuve, I.M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Glick, S.D.</au><au>Pearl, S.M.</au><au>Cai, J.</au><au>Maisonneuve, I.M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ibogaine-like effects of noribogaine in rats</atitle><jtitle>Brain research</jtitle><addtitle>Brain Res</addtitle><date>1996-03-25</date><risdate>1996</risdate><volume>713</volume><issue>1</issue><spage>294</spage><epage>297</epage><pages>294-297</pages><issn>0006-8993</issn><eissn>1872-6240</eissn><coden>BRREAP</coden><abstract>Ibogaine is a naturally occurring alkaloid that has been claimed to be effective in treating addiction to opioids and stimulants; a single dose is claimed to be effective for 6 months. Analogously, studies in rats have demonstrated prolonged (one or more days) effects of ibogaine on morphine and cocaine self-administration even though ibogaine is mostly eliminated from the body in several hours. These observations have suggested that a metabolite may mediate some of the effects of ibogaine. Recently, noribogaine was identified as a metabolite of ibogaine. Accordingly, the present study sought to determine, in rats, whether noribogaine had pharmacological effects mimicking those of ibogaine. Noribogaine (40 mg/kg[ was found to decrease morphine and cocaine self-administration, reduce the locomotor stimulant effect of morphine, and decrease extracellular levels of dopamine in the nucleus accumbens and striatum. All of these effects were similar to effects previously observed with ibogaine (40 mg/kg[; however, noribogaine did not induce any ibogaine-like tremors. The results suggest that noribogaine may be a mediator of ibogaine's putative anti-addictive effects.</abstract><cop>London</cop><cop>Amsterdam</cop><cop>New York, NY</cop><pub>Elsevier B.V</pub><pmid>8725004</pmid><doi>10.1016/0006-8993(95)01563-9</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-8993
ispartof Brain research, 1996-03, Vol.713 (1), p.294-297
issn 0006-8993
1872-6240
language eng
recordid cdi_proquest_miscellaneous_17055103
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Biological and medical sciences
Cocaine
Dopamine
Drug addictions
Drug self-administration
Female
Ibogaine
Ibogaine - analogs & derivatives
Ibogaine - pharmacology
Locomotion - drug effects
Medical sciences
Medicine, African Traditional
Microdialysis
Morphine
Morphine - pharmacology
Noribogaine
Rats
Rats, Sprague-Dawley
Self Administration
Substance-Related Disorders - therapy
Time Factors
Toxicology
title Ibogaine-like effects of noribogaine in rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T23%3A23%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ibogaine-like%20effects%20of%20noribogaine%20in%20rats&rft.jtitle=Brain%20research&rft.au=Glick,%20S.D.&rft.date=1996-03-25&rft.volume=713&rft.issue=1&rft.spage=294&rft.epage=297&rft.pages=294-297&rft.issn=0006-8993&rft.eissn=1872-6240&rft.coden=BRREAP&rft_id=info:doi/10.1016/0006-8993(95)01563-9&rft_dat=%3Cproquest_cross%3E17055103%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17055103&rft_id=info:pmid/8725004&rft_els_id=0006899395015639&rfr_iscdi=true